BioX­cel looks to ex­pand la­bel to at-home use for lead psych drug. Ini­tial da­ta are mixed

BioX­cel re­port­ed Thurs­day morn­ing that Igal­mi, a drug ap­proved to treat ag­i­ta­tion in pa­tients with cer­tain psy­chi­atric dis­or­ders …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.